JournalsHub
.online
Find My Journal
SP

Sandrina Phipps

Quality Biological US

48
Publications
655
Citations
11
H-Index
11
i10-Index
3.33
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable Endostatin OA
Keisuke Mori, Akira Ando, Peter Gehlbach, David J. Nesbitt, Kyoichi Takahashi +11 more
American Journal Of Pathology 2001
160
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
John Jakubczak, Patricia C. Ryan, M Gorziglia, Lori Clarke, Lynda K. Hawkins +11 more
PubMed 2003
99
Antiangiogenic Gene Therapy for Cancer via Systemic Administration of Adenoviral Vectors Expressing Secretable Endostatin
Cheauyun T. Chen, Jane Lin, Qin Li, Sandrina Phipps, John Jakubczak +6 more
Human Gene Therapy 2000
88
SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
Krista Kinneer, John Meekin, Arnaud Tiberghien, Yu‐Tzu Tai, Sandrina Phipps +13 more
Clinical Cancer Research 2018
83
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer OA
Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, Kelly McGlinchey, Weichuan Luo +24 more
Journal of Clinical Investigation 2023
45

Publications

48 total

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers PDF

Allison M. Barrett, Zachary T. Britton, Rosa A. Carrasco, Shannon Breen, Maria A.S. Broggi et al. - Clinical Cancer Research, 2024
Cited by 31 OpenAlex

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer PDF

Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, Kelly McGlinchey, Weichuan Luo et al. - Journal of Clinical Investigation, 2023
Cited by 45 OpenAlex

Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR

Shenlan Mao, Raghothama Chaerkady, Wen Yu, Gina D’Angelo, Andrew Garcia et al. - Molecular Cancer Therapeutics, 2021
Cited by 31 OpenAlex

A high yielding IFNAR1 ECD mammalian expression process for use in autoimmune disease drug development PDF

Caroline Kittinger, Arnita Barnes, Alan K. Hunter, LeeAnn Machiesky, Sandrina Phipps et al. - Protein Expression and Purification, 2019
Cited by 3 OpenAlex

Abstract 13869: Immortalization of Human Neonatal C-kit+ Cardiac Progenitor Cells Preserves Their Phenotype and Function at High Passage

Emily L. Ongstad, Rachana Mishra, Mehdi Belkhodja, Sudhish Sharma, Ranjitha Gaddipati - Unknown Venue, 2019
Cited by 0 Semantic Scholar

SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads

Krista Kinneer, John Meekin, Arnaud Tiberghien, Yu‐Tzu Tai, Sandrina Phipps et al. - Clinical Cancer Research, 2018
Cited by 83 OpenAlex

Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti–Pseudomonas aeruginosa antibodies PDF

M. Jack Borrok, Antonio DiGiandomenico, Nurten Beyaz, Gabriela M. Marchetti, Arnita Barnes et al. - JCI Insight, 2018
Cited by 25 OpenAlex

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer PDF

Emily E. Bosco, R. James Christie, Rosa A. Carrasco, Darrin Sabol, Jiping Zha et al. - Oncotarget, 2018
Cited by 17 OpenAlex

Abstract A138: Loss of the lysosomal transporter SLC46A3 is a mechanism for innate and acquired resistance to non-cleavable maytansine and pyrrolobenzodiazepine-based antibody-drug conjugates

Krista Kinneer, John H Meekin, Sandrina Phipps, Binyam Z Bezabeh, R. Fleming - Unknown Venue, 2018
Cited by 0 Semantic Scholar

Abstract 759: Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer

E. Bosco, R. Christie, R. Carrasco, Darrin Sabol, J. Zha - Experimental and Molecular Therapeutics, 2018
Cited by 0 Semantic Scholar

Research Topics

Genetics and Neurodevelopmental Disorders (12) CAR-T cell therapy research (11) Nuclear Receptors and Signaling (10) HER2/EGFR in Cancer Research (9) Cancer Immunotherapy and Biomarkers (8)

Frequent Co-Authors

JO
John Jakubczak
3 joint publications
YE
Yelena Skripchenko
3 joint publications
SU
Suzanne Forry‐Schaudies
3 joint publications
PA
Paul L. Hallenbeck
3 joint publications
JO
John Meekin
3 joint publications
RO
Ronald Herbst
3 joint publications

Affiliations

Novartis (Switzerland)
CH 1999 - 1999
Quality Biological
US 2024 - 2024
Novartis (United States)
US 2004 - 2001
Biolog (United States)
US 2023 - 2023
AstraZeneca (United States)
US 2024 - 2019

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now